Journal article
Metabolic activation of PCBs to carcinogens in vivo—A review
Environmental toxicology and pharmacology, Vol.25(2), pp.241-246
2008
DOI: 10.1016/j.etap.2007.10.029
PMCID: PMC2364599
PMID: 18452002
Abstract
Many higher-chlorinated biphenyls, persistent and predominant in foods, are active as promoters in hepatocarcinogenesis. Lower-chlorinated biphenyls, predominating in indoor and outdoor air, are more readily metabolized and therefore shorter lived, ‘episodic’ contaminants. Thus inhalation of such lower-chlorinated biphenyls may expose humans to reactive, possibly genotoxic/carcinogenic intermediates. Lower-chlorinated biphenyls may be metabolized via arene-oxides to mono- and di-hydroxylated intermediates and further to (semi)quinones, highly reactive intermediates. Covalently bound lower-chlorinated biphenyls have been detected in rodent tissues
in vivo. We recently showed using the modified Solt–Farber foci assay that several mono- to tetrachlorinated biphenyls have initiating activity in the livers of rats. In a follow-up study of PCB3 (4-chlorobiphenyl) metabolites, only one monohydroxy- and one quinoid-metabolite showed initiating activity, indicating that the metabolic activation of PCB3 proceeds via hydroxylation and oxidation to the 3,4-quinone, the ultimate carcinogen. Since cancer initiation is based on genotoxic event(s), we hypothesized that PCB3 and/or its metabolite(s) are mutagenic in rat liver
in vivo. To investigate this, BigBlue
® rats, transgenic for the
lacI reporter gene, were exposed to PCB3 and 4-hydroxy-PCB3 (4-HO-PCB3). In male rats the mutant frequency (MF) of
lacI in the liver was significantly elevated and the mutation spectrum differed significantly from the control. 4-HO-PCB3 caused a non-significant (
p
=
0.115) doubling of the MF compared to the control. These studies prove that lower halogenated biphenyls may be metabolically activated
in vivo to genotoxic and initiating intermediates.
Details
- Title: Subtitle
- Metabolic activation of PCBs to carcinogens in vivo—A review
- Creators
- Gabriele Ludewig - Department of Occupational & Environmental Health, College of Public Health, University of Iowa, 100 Oakdale Campus, #234 IREH, Iowa City, IA 52242-5000, USALeane Lehmann - Institute of Applied Biosciences, University of Karlsruhe, Kaiserstrasse 12, D-76131 Karlsruhe, GermanyHarald Esch - BASF Aktiengesellschaft, Ludwigshaven, GermanyLarry W Robertson - Department of Occupational & Environmental Health, College of Public Health, University of Iowa, 100 Oakdale Campus, #234 IREH, Iowa City, IA 52242-5000, USA
- Resource Type
- Journal article
- Publication Details
- Environmental toxicology and pharmacology, Vol.25(2), pp.241-246
- DOI
- 10.1016/j.etap.2007.10.029
- PMID
- 18452002
- PMCID
- PMC2364599
- NLM abbreviation
- Environ Toxicol Pharmacol
- ISSN
- 1382-6689
- eISSN
- 1872-7077
- Publisher
- Elsevier BV
- Language
- English
- Date published
- 2008
- Academic Unit
- Occupational and Environmental Health; Iowa Superfund Research Program
- Record Identifier
- 9983997330502771
Metrics
21 Record Views